Cost ‐effectiveness of Cetuximab as a treatment strategy for metastatic colon cancer in Peru: chemotherapy/Cetuximab versus chemotherapy alone

ConclusionsThe cost/QALY was S/. 20  078 (1 local GDP‐pc) for the intervention with CT plus cetuximab. Other results of clinical relevance, such as ‘additional R0‐resections’, ‘additional ETS cases’, ‘disease progressions avoided’ and ‘deaths avoided’ also favour the combination treatment.
Source: Journal of Pharmaceutical Health Services Research - Category: Drugs & Pharmacology Authors: Tags: Research Paper Source Type: research